Optimizing Oncology Trial Recruitment and Site Readiness
Complex oncology trials face mounting pressure as biomarker-driven protocols narrow patient eligibility, often stalling enrollment before it begins. On October 7, 2026, industry experts will convene for an Xtalks webinar to address these systemic delays, focusing on early site engagement and refined feasibility strategies to accelerate study timelines.
The discussion will dissect the specific hurdles inherent in modern clinical research, where identifying patients with precise genetic mutations remains a primary bottleneck. Experts, including Chloe Rose of Pratia and Dr. Julio Peguero, will examine how referral pathways and site capabilities must be calibrated to meet the distinct demands of Phase I versus later-phase studies.
Beyond technical recruitment, the session will contrast the operational landscapes of the US and European markets. By identifying barriers during the start-up phase, sponsors and CROs can improve site readiness and move toward more predictable enrollment cycles. Interested professionals can register for the live event, scheduled for 10:00 am EDT, to gain insights into bridging the gap between protocol design and patient access.
Comments (0)
No comments yet. Be the first!